Last Week Events
Everything at a Glance!
Stay up to date on the most significant events in the SPAC and IPO space! From upcoming public offerings to merger votes, we provide a centralized overview of all key dates.
Last Week Events
Everything at a Glance!
Stay up to date on the most significant events in the SPAC and IPO space! From upcoming public offerings to merger votes, we provide a centralized overview of all key dates.
SPAC / IPO Events from Feb 02, 26 to Feb 06, 26
Stay ahead with the newest SPAC & IPO events — start your 14-day free trial now.
| details_shortcode_en | Status | Industry |
|---|---|---|
SPAC
Unit Split
Unit Split:
Feb 02, 2026  Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: BLANK CHECKS
Presentation:
N/A
Press Release:
Jan 28, 2026 5:23 PM ET Bluerock Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about February 2, 2026 About Bluerock Acquisition Corp.: Bluerock Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our... |  | SPAC |
SPAC
Initial Public Offering / IPO SPAC
IPO / SPAC:
Feb 02, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies.
Presentation:
N/A
Press Release:
N/A About White Pearl Acquisition Corp.: White Pearl Acquisition Corp. is a blank check company incorporated as a BVI business company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. Although there is no restriction or limitation on what industry or geographic region our target operates in, it is our intention to... | | SPAC |
Biotechnology
Initial Public Offering / IPO
IPO:
Feb 02, 2026  Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: PHARMACEUTICAL PREPARATIONS
Presentation:
N/A
Press Release:
N/A About Polaryx Therapeutics, Inc.: We are a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”). Our therapeutic philosophy is centered on delivering safe, effective, and patient-friendly treatments that address the underlying pathophysiology of these catastrophic diseases and their significant unmet need. Our multi-modal approach integrates small molecule therapies, including a... |  | Biotechnology |
|
SPAC
Initial Public Offering / IPO SPAC
IPO / SPAC:
Feb 03, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies.
Presentation:
N/A
Press Release:
N/A About Iris Acquisition Corp. II: Iris Acquisition Corp II, a Cayman Islands exempted company (the “Company”), is a newly organized blank check company or special purpose acquisition company (“SPAC”), formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our “initial business combination.” We have not selected any... | | SPAC |
Raw Materials
Initial Public Offering / IPO
IPO:
Feb 10, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: METAL MINING
Presentation:
Jan 26, 2026 5:02 PM ET
Press Release:
N/A About Jaguar Uranium Corp.: We are a uranium exploration and development company focused on uranium discoveries. We maintain significant land holdings in Colombia and Argentina and our portfolio is comprised of two uranium exploration projects in Argentina (the “Laguna Project” and the “Huemul Project”, referred collectively as “Argentina Projects”) and one exploration project in Colombia (the “Berlin Project” and together with the Argentina Projects, our “Properties”), which offer substantial... | | Raw Materials |
|
SPAC
Initial Public Offering / IPO SPAC
IPO / SPAC:
Feb 04, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies.
Presentation:
N/A
Press Release:
N/A About Colombier Acquisition Corp. III: Colombier Acquisition Corp. III is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive... | | SPAC |
|
SPAC
Unit Split
Unit Split:
Feb 04, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: BLANK CHECKS
Presentation:
N/A
Press Release:
Jan 30, 2026 4:34 PM ET Lafayette Digital Acquisition Corp. I Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing February 4, 2026 About Lafayette Digital Acquisition Corp. I: Lafayette Digital Acquisition Corp. I is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated... | | SPAC |
Biotechnology
Definitive Agreement
Definitive Agreement:
Feb 04, 2026  Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: BLANK CHECKS
Presentation:
N/A
Press Release:
Feb 04, 2026 8:05 AM ET PrimeGen US, Inc. Announces Proposed Business Combination with DT Cloud Star Acquisition Corporation at an Implied Equity Value of Approximately $1.5 Billion to Advance Its Stem Cell Research and Development Efforts About PrimeGen US, Inc.: PrimeGen US is a regenerative medicine company, leveraging nearly two decades of proprietary stem cell research to develop Triple Activated Mesenchymal Stem Cells (MSCs) as a novel, cell-based treatment for acute liver injury and related critical conditions. The Company’s platform has demonstrated in preclinical activity in animal studies, and recent advancements include completion of a Pre-Investigational New Drug application (Pre-IND) meeting for Acute Alcoholic Hepatitis (Acute Liver... |  | Biotechnology |
Health
Initial Public Offering / IPO
IPO:
Feb 04, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: PHARMACEUTICAL PREPARATIONS
Presentation:
N/A
Press Release:
N/A About Veradermics, Inc: We are a dermatologist-founded, late clinical-stage biopharmaceutical company focused on developing innovative therapeutics to address pervasive treatment challenges in highly prevalent aesthetic and dermatological conditions. Our initial focus is developing better treatments for pattern hair loss, or PHL, a condition affecting approximately 50 million men and 30 million women in the United States. Current PHL treatment options are limited and therefore are consistently plagued with high rates... | | Health |
Consumer Goods
Initial Public Offering / IPO
IPO:
Feb 05, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: FURNITURE STORES
Presentation:
N/A
Press Release:
N/A About Bob's Discount Furniture, Inc.: Bob’s Discount Furniture is a rapidly growing, nationally proven omnichannel retailer of value home furnishings with 206 showrooms as of September 28, 2025 across 26 U.S. states. Since our founding in 1991, we have built our ethos as a trusted and reliable brand offering superior value and service, without compromising on quality or style. Our business model is anchored in delivering furniture at “Everyday Low Prices,” which we estimate results in our prices being on average approximately... | | Consumer Goods |
|
Biotechnology
Initial Public Offering / IPO
IPO:
Feb 05, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Presentation:
N/A
Press Release:
N/A About Eikon Therapeutics, Inc.: We are a late-stage clinical biopharmaceutical company dedicated to building a global, fully-integrated organization developing important, innovative medicines to address serious unmet medical needs. We are led by world-renowned drug developers Dr. Roger M. Perlmutter, M.D., Ph.D., and Dr. Roy Baynes, M.D., Ph.D. Our vision is to become a generational leader, by purposefully integrating traditional biology research with advanced engineering to develop better medicines faster. Our initial focus... | | Biotechnology |
Materials
Initial Public Offering / IPO
IPO:
Feb 05, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: ELECTRICAL INDUSTRIAL APPARATUS
Presentation:
N/A
Press Release:
N/A About Forgent Power Solutions, Inc.: We are a leading designer and manufacturer of electrical distribution equipment used in data centers, the power grid and energy-intensive industrial facilities. Demand for our products is growing rapidly as (i) companies accelerate investment in data centers to meet the computational requirements for cloud computing and AI, (ii) independent power producers build new generation capacity to satisfy rising electricity demand, (iii) utilities upgrade and expand T&D infrastructure to address... | | Materials |
|
SPAC
Initial Public Offering / IPO SPAC
IPO / SPAC:
Feb 06, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: BLANK CHECKS
Presentation:
N/A
Press Release:
N/A About Cambridge Acquisition Corp.: Cambridge Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any... | | SPAC |
|
SPAC
Unit Split
Unit Split:
Feb 06, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: BLANK CHECKS
Presentation:
N/A
Press Release:
Feb 05, 2026 3:24 PM ET Iron Horse Acquisition II Corp. Announces the Separate Trading of its Ordinary Shares and Rights Commencing February 6, 2026 About Iron Horse Acquisition II Corp.: Iron Horse Acquisitions Corp. II (the “Company”) is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities, which we refer to as a “target business.” Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region although we intend to initially focus... | | SPAC |
|
SPAC
Initial Public Offering / IPO SPAC
IPO / SPAC:
Feb 06, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: BLANK CHECKS
Presentation:
N/A
Press Release:
Feb 09, 2026 5:10 PM ET SPACSphere Acquisition Corp. Announces the Closing of $172,500,000 Initial Public Offering About SPACSphere Acquisition Corp.: SPACSphere Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific target business and we have not, nor has anyone on our behalf, initiated any substantive... | | SPAC |
|
Biotechnology
Initial Public Offering / IPO
IPO:
Feb 06, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Presentation:
Jan 16, 2026 4:19 PM ET
Press Release:
Feb 09, 2026 4:18 PM ET Agomab Announces Closing of Initial Public Offering About Agomab Therapeutics NV: We are a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Our product candidates are designed to target established pathways and utilize validated modalities with the aim of increasing efficacy while avoiding systemic toxicities in order to overcome the limitations of prior therapeutic approaches. Our initial focus for the... | | Biotechnology |
Media
Initial Public Offering / IPO
IPO:
Feb 06, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: COMPUTER PROCESSING & DATA PREPARATION
Presentation:
N/A
Press Release:
N/A About Liftoff Mobile, Inc. : Liftoff is a mission-critical growth monetization engine for the app economy. Our AI-powered platform is designed to serve all verticals in the app ecosystem and is fully integrated to drive differentiated advertising performance for our customers across the app economy. We deliver profitable users for app advertisers and help to maximize advertising revenue for apps that monetize with ads. For each of the twelve months ending December 31, 2023 and 2024 and September 30, 2025, 643, 728 and 871... | | Media |
|
Consumer Goods
Initial Public Offering / IPO
IPO:
Feb 06, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: FOOD AND KINDRED PRODUCTS
Presentation:
N/A
Press Release:
N/A About Once Upon a Farm, PBC: At Once Upon a Farm, we are driving systemic change in childhood nutrition with real, organic, farm-fresh food–made with no added sugar, no preservatives, and nothing artificial. From baby’s first bites to kid’s school-ready snacks, we are a rapidly growing leader in modern childhood nutrition that provides innovative, nutrient-packed, delicious food to on-the-go parents for their babies and kids. We revolutionized the childhood nutrition category with what we believe is the first-ever... | | Consumer Goods |
|
Health
Initial Public Offering / IPO
IPO:
Feb 06, 2026 Show Chart?Load external content from TradingView! *You can change or withdraw your consent at any time in the footer under Cookies. Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Presentation:
N/A
Press Release:
Feb 09, 2026 4:22 PM ET SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares About SpyGlass Pharma, Inc.: We are a late-stage biopharmaceutical company dedicated to transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. Our mission is to significantly improve the lives of patients with chronic eye conditions by developing durable drug delivery solutions that can empower patients and surgeons with confidence in long-term disease control and vision preservation. | | Health |
Sneak Peek
Agomab Therapeutics Prices Initial Public Offering at $16.00 per ADS
Biotechnology
Initial Public Offering / IPOGet access to more now!
Articles in Period
| Period | Free / Member |
|---|---|
| 2026-02 | 0 / 125 |
| 2026-01 | 0 / 474 |
Start your free 14-day trial and unlock all articles and information on SPACs and IPOs.
Also Interesting
Klarna IPO (NYSE: KLAR) – BNPL giant with strong debut and Super-App ambitions
Financial Services
Initial Public Offering / IPO